Target intelligence / Profile preview

PABPN1 pseudogene 2 (PABPN1P2)

Target
PABPN1P2
Molecular classification
Other
01

Overview

PABPN1 pseudogene 2 (PABPN1P2) is a processed pseudogene related to the PABPN1 (polyadenylate-binding nuclear protein 1) gene, which encodes a key nuclear protein involved in messenger RNA polyadenylation, export, and quality control. Pseudogenes such as PABPN1P2 do not produce functional proteins and are generally not considered functional molecular targets, therapeutic targets, or disease-relevant biomarkers. As such, there are no known biological functions, disease associations, interacting drugs, or mechanisms of action for PABPN1P2. The canonical therapeutic target related to this pseudogene is PABPN1 (polyadenylate-binding nuclear protein 1, also known historically as PABP2 or OPMD protein). PABPN1 is involved in polyadenylation, mRNA export, and post-transcriptional regulation and is implicated in oculopharyngeal muscular dystrophy (OPMD) when mutated. However, none of these functions apply to the PABPN1P2 pseudogene, which lacks coding and regulatory function. Therefore, PABPN1P2 should NOT be considered a druggable target, receptor, enzyme, or transporter.

Other names
PABPN1P2PABPN1 pseudogene 2

Beyond the preview

Go deeper on PABPN1 pseudogene 2 (PABPN1P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PABPN1 pseudogene 2 (PABPN1P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call